BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Synta Pharmaceuticals 

45 Hartwell Avenue

Lexington  Massachusetts  02421  U.S.A.
Phone: 781-274-8200 Fax: 781-274-8228


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Synta Pharmaceuticals (SNTA) Enters Into Agreement To Sell $5.0 Million In Common Stock Directly To An Affiliate Of Synta Board Member Bruce Kovner 4/14/2014 9:35:18 AM    More...
Synta Pharmaceuticals (SNTA) Announces Positive Interim Results From The ENCHANT-1 Trial Of Ganetespib In Metastatic Breast Cancer At The 9th European Breast Cancer Conference 3/20/2014 10:22:17 AM    More...
Synta Pharmaceuticals (SNTA) Reports Fourth Quarter And Year-End 2013 Financial Results And Provides Corporate Update 3/11/2014 7:01:50 AM    More...
Synta Pharmaceuticals (SNTA) Announces Executive Management Changes, Appoints Dr. Paul A. Friedman Director 3/4/2014 7:01:05 AM    More...
Synta Pharmaceuticals (SNTA) To Present On Hsp90-inhibitor Drug Conjugate Platform At The 12th International Congress On Targeted Anticancer Therapies 3/3/2014 7:15:39 AM    More...
Synta Pharmaceuticals (SNTA) To Present At Upcoming Conferences 2/28/2014 7:12:29 AM    More...
Synta Pharmaceuticals (SNTA) To Host Conference Call And Webcast Of Fourth Quarter And Year-End 2013 Financial Results On March 11, 2014 2/27/2014 7:11:59 AM    More...
Synta Pharmaceuticals (SNTA) Reports On Progress With Lead HDC Compounds At IASLC Conference 2/24/2014 6:43:06 AM    More...
Synta Pharmaceuticals (SNTA) Announces Upcoming Oral Presentations On Hsp90-Inhibitor Drug Conjugate (HDC) Platform 2/18/2014 9:56:40 AM    More...
Synta Pharmaceuticals (SNTA) Announces Initiation Of Three Multicenter, Randomized Phase II/III Trials Of Ganetespib In Acute Myeloid Leukemia (AML) And High Risk Myelodysplastic Syndrome (MDS) 1/10/2014 8:53:16 AM    More...
12345678910...